Hannes Smarason, co-founder and chief executive officer for WuXi NextCode. Photo: The Washington Post/Josh Reynolds

China’s ‘precision medicine’ initiative gets lift from latest genomics company funding

Yunfeng Capital, Temasek lead US$75 million Series B funding round in contract genomics services provider Wuxi NextCode

Topic |   China innovators

TOP PICKS

Hannes Smarason, co-founder and chief executive officer for WuXi NextCode. Photo: The Washington Post/Josh Reynolds
READ FULL ARTICLE